Cargando...
Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients
Background and Objectives Liraglutide, an analog of human glucagon-like peptide 1 (GLP-1), has been approved for the treatment of type 2 diabetes mellitus in Pakistan since 2016. It is a GLP-1 receptor agonist that has shown promising results in terms of not only glycemic control but also weight los...
Guardado en:
| Publicado en: | Cureus |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Cureus
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7449611/ https://ncbi.nlm.nih.gov/pubmed/32864274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9937 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|